Pathstone Family Office’s CryoPort CYRX Stock Holding History

Pathstone Family Office’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$165K	Buy	+12,049	New	+$177K	﹤0.01%	1550

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Pathstone Family Office's CYRX Position: Q3 2023 in Review

Pathstone Family Office opened a new position in CryoPort (CYRX) in Q3 2023: 12,049 shares worth $165K. The stake represents ﹤0.01% of the portfolio and ranks #1550 among its holdings.

158 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

Pathstone Family Office held 12,049 shares of CryoPort worth $165K as of Q3 2023.
CryoPort was a new Pathstone Family Office position in Q3 2023.
CryoPort made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1550 holding.
158 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.